Abstract
Background and Objective: Systemic lupus erythematosus (SLE) is a diverse autoimmune disorder, evoked in response to self-immune system that leads to immune complex depositions and organ damage. The exact mechanism of SLE pathogenesis is still unclear but certain genetic and environmental factors have been suggested that could influence its pathogenesis.
Discussion: The modulation in B- and T- cell responses and genetic variations could lead to abnormal lymphocyte functions and the production of antibodies against the indigenous proteins and the immune complex depositions.
Conclusion: The present review highlights the various causatives of SLE, particularly the genetic alteration in B- and T-cell-related proteins. We have also delineated some of the available therapeutic strategies for the treatment of SLE.
Keywords: Cytokines, inflammation, interferons, polymorphism, pathogenesis, systemic lupus erythematosus.
Endocrine, Metabolic & Immune Disorders - Drug Targets
Title:An Insight on the Pathogenesis and Treatment of Systemic Lupus Erythematosus
Volume: 18 Issue: 2
Author(s): Murtaza Ali, Chelapram K. Firoz, Nasimudeen R. Jabir, Mohd Rehan, Mohd S. Khan and Shams Tabrez*
Affiliation:
- King Fahd Medical Research Center, King Abdulaziz University, Jeddah,Saudi Arabia
Keywords: Cytokines, inflammation, interferons, polymorphism, pathogenesis, systemic lupus erythematosus.
Abstract: Background and Objective: Systemic lupus erythematosus (SLE) is a diverse autoimmune disorder, evoked in response to self-immune system that leads to immune complex depositions and organ damage. The exact mechanism of SLE pathogenesis is still unclear but certain genetic and environmental factors have been suggested that could influence its pathogenesis.
Discussion: The modulation in B- and T- cell responses and genetic variations could lead to abnormal lymphocyte functions and the production of antibodies against the indigenous proteins and the immune complex depositions.
Conclusion: The present review highlights the various causatives of SLE, particularly the genetic alteration in B- and T-cell-related proteins. We have also delineated some of the available therapeutic strategies for the treatment of SLE.
Export Options
About this article
Cite this article as:
Ali Murtaza , Firoz K. Chelapram, Jabir R. Nasimudeen , Rehan Mohd , Khan S. Mohd and Tabrez Shams *, An Insight on the Pathogenesis and Treatment of Systemic Lupus Erythematosus, Endocrine, Metabolic & Immune Disorders - Drug Targets 2018; 18 (2) . https://dx.doi.org/10.2174/1871530318666171207145003
DOI https://dx.doi.org/10.2174/1871530318666171207145003 |
Print ISSN 1871-5303 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3873 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Recent Advancement and Technological Aspects of Pulsatile Drug Delivery System - A Laconic Review
Current Drug Targets Pharmacogenetics in Type 2 Diabetes: Polymorphisms in Candidate Genes Affecting Responses to Antidiabetic Oral Treatment
Current Pharmacogenomics Does Phosphodiesterase 11A (PDE11A) Hold Promise as a Future Therapeutic Target?
Current Pharmaceutical Design Characterization of Substituted Phenylpropylamides as Highly Selective Agonists at the Melatonin MT2 Receptor
Current Medicinal Chemistry Effects of CYP2C19 Polymorphism on Endothelial Function, Arterial Stiffness and Inflammation in Coronary Artery Disease Patients Under Clopidogrel Treatment
Current Pharmaceutical Design Current Protein-based Anti-angiogenic Therapeutics
Mini-Reviews in Medicinal Chemistry Two Promising Anti-Cancer Compounds, 2-Hydroxycinnaldehyde and 2- Benzoyloxycinnamaldehyde: Where do we stand?
Combinatorial Chemistry & High Throughput Screening Determination of Disulfide Functionality in Underivatised Peptides Using Negative Ion Mass Spectrometry: An Aid to Structure Determination
Current Analytical Chemistry Emerging Molecular Targets for Treatment of Erectile Dysfunction: Vascular and Regenerative Therapies on the Horizon
Current Drug Targets GATA-3 as a Potential Therapeutic Target for Insulin Resistance and Type 2 Diabetes Mellitus
Current Diabetes Reviews Current Advances in Delivery of Biotherapeutics Across the Blood-Brain Barrier
Current Drug Discovery Technologies Inorganic Phosphate as a Signaling Molecule: A Potential Strategy in Osteosarcoma Treatment
Current Pharmaceutical Design Atom-based 3D-QSAR and Docking Studies of Various 3-aminomethyl- 1,2-dihydro-4-phenyl-1-isoquinolones Derivatives as an Effective DPP-IV Inhibitors and its Validation
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Drug Acyl Glucuronides: Reactivity and Analytical Implication
Current Pharmaceutical Analysis Anti-tumoral Properties of Endogenous Angiogenesis Inhibitors: A Case for Continued TIMP-2 Preclinical Development
Current Angiogenesis (Discontinued) Influence of Polymorphic N-Acetyltransferases on Non-Malignant Spontaneous Disorders and on Response to Drugs
Current Drug Metabolism Obesity and Inflammation – Targets for OA Therapy
Current Drug Targets Review of Airway Illnesses by Kytococcus and Rothia and a Look at Inhalatory Vancomycin as a Treatment Support
Recent Patents on Anti-Infective Drug Discovery GABAA Receptors in Normal Development and Seizures: Friends or Foes?
Current Neuropharmacology Graphical Abstracts
Current Organic Chemistry